Content must not be changed in any way or reproduced in any format or medium without the formal permission of the copyright holder(s)

Similar documents
Dementia Post- Diagnostic Support

OHTAC Recommendation

Sacral neuromodulation (SNM), using permanent foramen S3 electrode, Early versus late treatment of voiding dysfunction with pelvic neuromodulation

03/13/18. A. Symptoms lasting for greater than or equal to 12 months that have resulted to significant impairment in activities of daily living; and

Alcohol-Related Hospital Statistics Scotland 2015/16

Sacral Neuromodulation Beyond Pelvic Pain!!!

Child Health Month Review Statistics

Coding for Sacral Neuromodulation

Surgical management of stress urinary incontinence in Scotland and Wales: A questionnaire study

Second-line Treatment for OAB

SUBJECT: HPV vaccination programme update

The cost of the Axonics sacral neuromodulation system is 475 for the trial phase, 9,210 for a

Child Health Month Review Statistics

Abdominal Aortic Aneurysm (AAA) Screening. Date: 7 March 2017 Version: 1.0

Tertiary, regional and local pelvic floor service providers: the future. model? Andrew Williams

Alcohol-related Hospital Statistics Scotland 2011/12

Drug-Related Hospital Statistics Scotland 2014/15

HPV Immunisation Statistics Scotland

Scottish Bowel Screening Programme Statistics

abcdefghijklmnopqrstu

HPV Immunisation Statistics Scotland

University College Hospital at Westmoreland Street. Percutaneous Tibial Nerve Stimulation (PTNS)

Scottish Bowel Screening Programme Statistics

Places and communities that support and promote good health

ADHD Medication Prescribing in Scotland in 2016/17

Long Acting Reversible Methods of Contraception (LARC) in Scotland

Incidence of new patients starting RRT

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

PARTICULARS, SCHEDULE 2- THE SERVICES, A- SERVICE SPECIFICATIONS. A08/S/d Colorectal: Faecal Incontinence (Adult)

This is the author s final accepted version.

Patient Information. Basic Information on Overactive Bladder Symptoms. pubic bone. urethra. scrotum. bladder. vaginal canal

Overactive Bladder Syndrome

2012/13 NHS STANDARD CONTRACT FOR ACUTE, AMBULANCE, COMMUNITY AND MENTAL HEALTH AND LEARNING DISABILITY SERVICES (MULTILATERAL)

NEUROMODULATION FOR UROGYNAECOLOGISTS

Posterior Tibial Nerve Stimulation

Scottish mental health profiles for adults: summary report. Andrew D Millard, Gerry McCartney

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Stimulation of the Sacral Anterior Root Combined with Posterior Sacral Rhizotomy in Patients with Spinal Cord Injury. Original Policy Date

Objective: To describe a new approach to neighborhood effects studies based on residential mobility and demonstrate this approach in the context of

Child: care, health and development

NEUROGENIC BLADDER. Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph

Management of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals

Information for Patients. Overactive bladder syndrome (OAB) English

Posterior Tibial Nerve Stimulation for Voiding Dysfunction

Cabazitaxel (XRP-6258) for hormone refractory, metastatic prostate cancer second line after docetaxel

Sacral Nerve Neuromodulation / Stimulation

2. CANCER AND CANCER SCREENING

Health Inequalities and Community Profiling in the Western Isles. Martin Malcolm, Head of Public Health Intelligence, NHS Western Isles

Urodynamic Results of Sacral Neuromodulation Correlate with Subjective Improvement in Patients with an Overactive Bladder

Scottish Abdominal Aortic Aneurysm Screening Programme Statistics

Overactive Bladder in Clinical Practice

Policy for Prostatism/Lower Urinary Tract Symptoms in men

Botox (Botulinum Toxin) injections into the bladder

Scottish Bowel Screening Programme Statistics

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women

abcdefghijklmnopqrstu

BEST PRACTICE ADVOCACY CENTRE NEW ZEALAND SCOPE. Urinary incontinence in women: the management of urinary incontinence in women

Selective Dorsal Rhizotomy (SDR) Scotland Service Pathway

Neuromodulation and the pudendal nerve

Access to Male & Female Sterilisation

PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) TREATMENT FOR URINARY INCONTINENCE SECONDARY CARE PRIOR APPROVAL POLICY

Guidelines for referring patients to Physiotherapy for the treatment of Pelvic Floor Dysfunction

Intravesical Botox Injections

Clinical Policy: Urinary Incontinence Devices and Treatments

Sacral neuromodulation for lower urinary tract dysfunction

Bladder dysfunction in ALD and AMN

NHSScotland Psychology Services

HPV Immunisation Uptake Statistics for the Catch-up Programme

Long Acting Reversible Methods of Contraception (LARC) Key Clinical Indicator

SUMMARY: YEAR OLDS WITH CANCER IN ENGLAND: INCIDENCE, MORTALITY AND SURVIVAL (2018)

A joint venture between the Department of Uro-Neurology, Queen Square, University College London and the Neuro-Urology Promotion Committee of the ICS

Adult obesity and socioeconomic status data factsheet

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

A Strategy for Increasing Standards of Care in Female, Neurological and Urodynamic Urology

Sacral Neuromodulation for Dysfunctional Voiders Workshop 1 Monday, August 23, 09:00 10:30

Sacral Nerve Neuromodulation/Stimulation

A framework for all staff working with people with Autism Spectrum Disorders, their families and carers

Sacral nerve stimulation for faecal incontinence

Primary 1 Body Mass Index (BMI) Statistics

Information about your operation: Sacral nerve stimulation (SNS)

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Medicines and Technologies Programme Adoption Scoping Report MTG315 Peristeen

The incidence of biopsy-proven IgA nephropathy is associated with multiple socioeconomic deprivation

Suicidal Behaviour among Young Adults (15-34 years)

Percutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms. Patient Information Leaflet

SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)

Integrated Continence Service Policy. January SafeCare Council January Carol Giffin, Continence Advisor

Population Based KCIs Data for 2006

Various Types. Ralph Boling, DO, FACOG

Population health profile of the. Mornington Peninsula. Division of General Practice: supplement

Impact of deprivation and rural residence on treatment of colorectal and lung cancer

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

NHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme

HIGH MORTALITY AND POOR SURVIVAL OF MEN WITH PROSTATE CANCER IN RURAL AND REMOTE AUSTRALIA

Randomised Mixed Methods Pilot Trial of Sacral and Percutaneous Tibial Nerve Stimulation for Faecal Incontinence

1st stage neuromodulation test

NHS Smoking Cessation Service Statistics (Scotland) 1 st January to 31 st December 2006

K D Lawson, 1 E A L Fenwick, 1 A C H Pell, 2 J P Pell 1. Epidemiology

Abdominal Aortic Aneurysm (AAA) Screening

Transcription:

n Lim, D., Ramsay, A., Small, D., and Conn, I. (2014) Socioeconomic demographics of patients referred to the Scottish National Service: sacral nerve stimulation for urinary dysfunction. Journal of Clinical Urology, 7 (3). pp. 198-201. ISSN 2051-4158. Copyright 2014 Sage Publications A copy can be downloaded for personal non-commercial research or study, without prior permission or charge Content must not be changed in any way or reproduced in any format or medium without the formal permission of the copyright holder(s) http://eprints.gla.ac.uk/99284/ Deposited on: 11 November 2014 Enlighten Research publications by members of the University of Glasgow http://eprints.gla.ac.uk

Journal of Clinical Urology May 2014 vol. 7 no. 3 198-201 Socioeconomic demographics of patients referred to the Scottish Sacral Nerve Stimulation (SNS) Service for Urinary Dysfunction Lim DBN 1, Ramsay AK 2, Small DR 2, Conn IG 2 1 School of Medicine, University of Glasgow, Glasgow G12 8QQ 2 Department of Urology, Southern General Hospital, Glasgow G51 4TF Corresponding Author: Mr I Graeme Conn, Consultant Urologist, Department of Urology, Southern General Hospital, Glasgow G51 4TF E-mail : ian.conn@nhs.net Tel: 0141 2011514 Fax: 0141 2012987 Keywords: sacral nerve stimulation, urinary dysfunction, selection, implantation, socioeconomic INTRODUCTION Sacral nerve stimulation (SNS), also known as sacral neuromodulation, has become a well-established treatment modality for patients with refractory lower urinary tract dysfunction 1. This is currently offered in tertiary referral urology centres across the United Kingdom with the Scottish Service being based in NHS Greater Glasgow and Clyde. With a relatively novel and technology based therapy such as SNS the doubt is present that the service might be more commonly offered to patients who have a higher socioeconomic status (SES) or higher level of education as the treatment does require patients to show understanding of the implant and the technology used. Mackenbach, for example, found that studies of the diffusion of innovations have observed that people with a higher socioeconomic position often tend to be early adopters, only later to be

followed by those with a lower social position 2. Other studies support the possibility that unconscious factors may bias the treatment offered on a socioeconomic basis 3,4. The Scottish Service, being a National Service is funded from top slicing each health board. Funding is available for a limited number of implants per annum and thus it is incumbent on the professionals delivering the service to appropriately select patients. This study was performed to attempt to allay any fears of bias on a socioeconomic basis by analysing our results to assess if this inadvertent discrimination was in fact present within our service. In order to do this we compared the SES of our referrals, of patients who were accepted for testing and also those who proceeded to permanent implantation. METHODS A retrospective review was performed of the electronic database containing records of all patients referred to the service since April 2010 to February 2013. Each patient s postcode was matched for its datazone rank and quintile based on the 2012 Scottish Index of Multiple Deprivation (SIMD) which assigns a number from 1 to 5 in descending order of deprivation 5. The SIMD is constructed using a spectrum of domains (income, employment, health, crime, geographic access to services, and education, skills and training); it identifies area concentrations of multiple deprivation across Scotland according to postcode, and then ranks each area (called datazone) by deprivation level. Quintiles split the datazones into 5 groups, each containing 20% of Scotland s datazones Quintile 1

contains Scotland s 20% most deprived datazones, Quintile 2 the next 20% most deprived and so on. In addition, the gender, age and eventual outcome post-referral of each patient were noted. Comparisons between patient proportions in each quintile were made using the twoproportion Z-test 6. Ninety five percent confidence intervals are shown in the figures 1-3. RESULTS Since April 2010, 217 patients were referred to the Scottish SNS Service. Of the 217, 43 were inappropriate referrals and were rejected. Forty four referrals were in urinary retention and the others had storage symptoms. One hundred and seventy eight patients were included in this study (3 were excluded due to incomplete data and 36 had not completed their pathways of care). Within our study population 30 were males and 148 were females, with a median age of 47.3 (range 16.7-81.1) years. The distribution of these patients by quintiles according to the SIMD is illustrated in Figure 1. Table 1 shows the comparison of patient proportions between quintiles and the resultant p-values. There were no significant differences in patient distribution between each quintile or against the expected population rate of 20% per quintile.

TABLE 1: Proportion of referred patients in each quintile compared with each other quintile. (largest difference highlighted in bold) Quintile 1 (41/178) 2 (38/178) 3 (35/178) 4 (30/178) 1 (41/178) 2 (21/178) p=0.702 3 (35/178) p=0.438 p=0.694 4 (30/178) p=0.145 p=0.281 p=0.493 5 (34/178) p=0.363 p=0.363 p=0.893 p=0.581 Of the 178 referrals, 101 (56.7%) were subsequently accepted for SNS testing using either peripheral nerve evaluation (PNE) or tined lead test (TLT). Figure 2 illustrates the

percentage of referral patients in each quintile progressing to this stage. There were no significant differences in patient proportion between each quintile (see Table 2). TABLE 2: Proportion of tested patients in each quintile compared with each other quintile. (largest difference highlighted in bold) Quintile 1 (26/41) 2 (21/38) 3 (20/35) 4 (15/30) 1 (26/41) 2 (21/38) p=0.461 3 (20/35) p=0.577 p=0.871 4 (15/30) p=0.259 p=0.666 p=0.564 5 (19/34) p=0.994 p=0.502 p=0.612 p=0.297

Of the 178 referrals, 65 (36.5%) were eventually selected for permanent implantation, of whom 6 were males and 59 were females, with a median age of 44.4 (range 17.2-78.6) years. Figure 3 illustrates the percentage of referral patients in each quintile progressing to this stage. There were again no significant differences in patient proportion between each quintile (see Table 3). TABLE 3: Proportion of implanted patients in each quintile compared with each other quintile. (largest difference highlighted in bold) Quintile 1 (16/41) 2 (17/38) 3 (14/35) 4 (7/30)

1 (16/41) 2 (17/38) p=0.607 3 (14/35) p=0.930 p=0.682 4 (7/30) p=0.163 p=0.067 p=0.152 5 (11/34) p=0.549 p=0.282 p=0.508 p=0.423 The difference between quintiles two and four might be speculated upon. It has not reached statistical significance, but a p value of 0.067 might be thought worth considering. It could be a random variation and this is likely, since there is no upward or downward trend in the data over the other quintiles. DISCUSSION Since its development in the 1980s, SNS has become an established option for treating patients with refractory lower urinary tract dysfunction. By using electrical pulses to activate or inhibit neural reflexes associated with lower urinary tract function via stimulation of the sacral nerves, SNS can modulate the control of bladder filling and emptying 1. Established in April 2010, the Scottish SNS Service for Urinary Dysfunction is a designated national service based at the New Victoria Hospital, Glasgow for the population of Scotland 5. The procedure is only considered in patient groups which benefit from SNS firstly, those who have intractable detrusor overactivity with symptoms of urinary frequency, urgency and urge incontinence, and secondly, those

who have non-obstructive urinary retention. Patients should also have been refractory to conservative treatment options including bladder re-training, anti-cholinergic medication and intra-vesical botulinum toxin. Patient selection for SNS is very stringent, as illustrated in the patient pathway of care in Figure 4. Permanent SNS implantation is reserved for patients who have been filtered through the initial stages and have proven benefit during stimulation testing (i.e. PNE and/or TLT). The permanent implant has a wireless external programmer and it is expected that with adequate instruction, patients can control the device independently In addition to patient selection being based purely on medical reasons, patients selected for permanent implantation need to have shown a minimum level of literacy and maturity, to have complied with the pre-implantation investigations and also shown facility with the implant technology. In this study we used the SIMD 2012 to measure deprivation. NHS Scotland currently recommends the use of the SIMD for point in time data analysis instead of the previous

Carstairs Index as the SIMD has the advantage of being a measure of multiple deprivation 7. Census data allows a best available estimate of the deprivation level of individuals residing there. Ideally, each individual s material deprivation would be measured using information on points such as income and employment or occupation. In practice, however an area-based measure is used such as the SIMD, as individual data collection is impractical. The SIMD is based on the patient's postcode. The postcode is used to determine which datazone each area matches to depending on which areas are deemed most deprived. A potential drawback to using this method is that postcodes are owned by the Royal Mail and can be geographically unstable. Over time as buildings are demolished or built the postcode may become a less reliable proxy for deprivation. Our hypothesis for this study was that that the Scottish SNS service unknowingly selected patients from a higher socioeconomic class as this group may be more likely to manage the technology. SES may be regarded as an indicator of education levels as research has linked lower SES to lower academic achievement and slower rates of academic progress as compared with higher SES communities 8. Lower urinary tract dysfunction is not associated with any risk factor related to deprivation. In this study we show that equal numbers of referrals arise from each quintile. We believe this to be due to the fact that referral to the Scottish SNS service is

made by a Urologist or Gynaecologist rather than by a General Practitioner. It is therefore not dependent on patients knowledge of SNS but rather on a specialist being aware of the service availability. Although this study shows no difference in referral according to SES, we are aware that there is a significant difference in referral depending on geography and whether or not the referrer has a specialist interest in urinary dysfunction. Although our results are reassuring we must continue to monitor SES as part of our service analysis to ensure no discrimination develops over time. CONCLUSIONS In a clinical service, decisions are by necessity made on a case by case basis. The overall provision of service may never be analysed for bias or implicit assumptions. We have analysed our patient pathway via a well validated and convenient indicator of deprivation and the hypothesis that we somehow discriminate has been rejected as our results show that patients referred, tested and treated by the Scottish SNS Service were equally distributed among all socioeconomic classes. REFERENCES 1. Kessler TM, Fowler CJ. Sacral neuromodulation for urinary retention. Nature Clinical Practice Urology. 2008;5(12):657-66 2. Mackenbach JP, The persistence of health inequalities in modern welfare states: The explanation of a paradox. Social Science & Medicine 2012; 75: 761-769

3. Campbell E, Hunt S, Kinney MO, et al. The effect of socioeconomic status on treatment and pregnancy outcomes in women with epilepsy in Scotland. Epilepsy & Behavior 2013; 28: 354 357. 4. Polonijo AN, Carpiano RM. Social inequalities in adolescent human papillomavirus (HPV) vaccination: A test of fundamental cause theory. Social Science & Medicine 2013; 82: 115-125. 5. The Scottish Government (2012) Scottish Index of Multiple Deprivation 2012. Available from: http://simd.scotland.gov.uk/publication-2012/ [Accessed 7 February 2013]. 6. Altman D. Practical Statistics for Medical Research. London: Chapman and Hall, 1991, p234 7. National Services Division Annual Report 2010/11. www.nsd.scot.nhs.uk/documents/2010-11nsdannrep.pdf 8. ISD Scotland (2012) Deprivation Measures: Guidance for ISD Analysts. www.isdscotland.org/products-and - Services/Deprivation/Deprivation_Measures_Guidance.pdf [Accessed 3 June 2013] 9. Palardy GJ. Differential school effects among low, middle and high social class composition schools: A multiple group, multilevel latent growth curve analysis. School Effectiveness and School Improvement. 2008;19:21-49